Apoptosis modulation of Epstein-Barr virus-encoded latent membrane protein 1 in the epithelial cell line HeLa is stimulus-dependent

Virology

Volumn 304, Issue 2, 2002, Pages 330-341

  Zhang, Xiangning ^a   Hu, LiFu ^a   Fadeel, Bengt ^b   Ernberg, Ingemar T ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

APO 1; Apoptosis; Caspases; CD95; Epstein Barr virus; Fas; Latent membrane protein 1; Tumor necrosis factor

Indexed keywords

CASPASE 3; ETOPOSIDE; FAS ANTIGEN; LATENT MEMBRANE PROTEIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; TETRACYCLINE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN A20;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; EPSTEIN BARR VIRUS; HELA CELL; HUMAN; HUMAN CELL; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SEQUENCE HOMOLOGY;

HUMAN HERPESVIRUS 4; MAMMALIA;

EID: 0036934692     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1640     Document Type: Article

References (51)

1. Abdulkarim, B., Sabri, S., Deutsch, E., Vaganay, S., Marangoni, E., Vainchenker, W., Bongrand, P., Busson, P., and Bourhis, J. (2000). Radiation-induced expression of functional Fas ligand in EBV-positive human nasopharyngeal carcinoma cells. Int. J. Cancer 86, 229-237.
2. An, S., and Knox, K. A. (1996). Ligation of CD40 rescues Ramos-Burkitt lymphoma B cells from calcium inophore- and antigen receptor-triggered apoptosis by inhibiting activation of the cysteine protease CPP32/Yama and cleavage of its substrate PARP. FEBS Lett. 386, 115-122.
3. An, S., Yap, D., and Knox, K. A. (1997). Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells. Cell Immunol. 181, 139-152.
4. Asoh, S., and Ohta, S. (1997). Bcl-2 completely blocks Fas-mediated apoptosis in mtDNA depleted HeLa cells. Biochem. Biophys. Res. Commun. 237, 659-662.
5. Busch, L. K., and Bishop G. A. (1999). The EBV transforming protein, latent membrane protein 1, mimics and cooperates with CD40 signaling in B lymphocytes. J. Immunol. 162, 2555-2561.
6. Devergne, O., McFarland, E. C., Mosialos, G., Izumi, K. M., Ware, C. F., and Kieff, E. (1998). Role of the TRAF binding site and NF-κB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression. J. Virol. 72, 7900-7908.
7. D'Souza, B., Rowe, M., and Walls, D. (2000). The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line. J. Virol. 74, 6652-6658.
8. Fadeel, B., Åhlin, A., Henter, J.-I., Orrenius, S., and Hampton, M. B. (1998). Involvement of caspases in neutrophil apoptosis: Regulation by reactive oxygen species. Blood 92, 4808-4818.
9. Fadeel, B., Thorpe, C. J., Yonehara, S., and Chiodi, F. (1997). Anti-IgG1 antibodies recognizing the same epitope of Fas/APO-1 mediate different biological effects in vitro. Int. Immunol. 9, 201-209.
10. Floettmann, J. E., Eliopoulos, A. G., Jones, M., Young, L. S., and Rowe, M. (1998). Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions. Oncogene 17, 2383-2392.
11. Floettmann, J. E., Ward, K., Rickinson, A. B., and Rowe, M. (1996). Cytostatic effect of Epstein-Barr virus latent membrane protein 1 analysed using tetracycline-regulated expression in B cells line. Virology 223, 29-40.
12. Foghsgaard, L., and Jäättelä, M. (1997). The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type. J. Virol. 71, 7509-7517.
13. Fries, K. L., Miller, W. E., and Raab-Traub, N. (1996). Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20. J. Virol. 70, 8653-8659.
14. Hanahan D., and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70.
15. Hardwick, J. M. (1998). Viral interference with apoptosis. Semin. Cell Dev. Biol. 9, 339-349
16. Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E., and Rickinson, A. B. (1991). Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65, 1107-1115.
17. Henderson, S., Huen, D., Rowe, M., Dawson C., Johnson, G., and Rickinson, A. (1993). Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA 90, 8479-8483.
18. Hu, L. F., Chen, F., Zhen, Q. F., Zhang, Y. W., Luo, Y., Zheng, X., Winberg, G., Ernberg, I., and Klein, G. (1995). Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomas. Eur. J. Cancer 31, 658-660.
19. Izumi, K. M., Cahir-McFarland, E., Ting, A. T., Riley, E. A., Seed, B., and Kieff, E. D. (1999). The Epstein-Barr virus oncoprotein latent membrane protein 1 enganges the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-κB activation. Mol. Cell. Biol. 19, 5759-5767.
20. Jäättelä, M., Mouritzen, H., Ellin, F., and Bastholm, L. (1996). A20 zinc finger protein inhibits TNF and IL-1 signaling. J. Immunol. 156, 1166-1173.
21. Kawanishi, M. (1997a). Expression of Epstein-Barr virus latent membrane protein 1 protects Jurkat T cells from apoptosis induced by serum deprivation. Virology 228, 244-250.
22. Kawanishi, M. (1997b). Epstein-Barr virus BHRF1 protein protects intestine 407 epithelial cells from apoptosis induced by tumor necrosis factor alpha and anti-Fas antibody. J. Virol. 71, 3319-3322.
23. Kawanishi, M. (2000). The Epstein-Barr virus latent membrane protein1 (LMP1) enhances TNF alpha-induced apoptosis of intestine 407 epithelial cells: The role of LMP1 C-terminal activation regions 1 and 2. Virology 270, 258-266.
24. Kaye, K. M., Izumi, K. M., and Kieff, E. (1993). Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 90, 9150-9154.
25. Krammer, P. H. (2000). CD95's deadly mission in the immune system. Nature 407, 789-795.
26. Kroemer, G., and Reed, J. C. (2000). Mitochondrial control of cell death. Nat. Med. 6, 513-519.
27. Laherty, C. D., Hu, H. M., Opipari, A. W., Wang, F., and Dixit, V. M. (1992). The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein by activating nuclear factor kappa B. J. Biol. Chem. 267, 24257-24260.
28. Liebowitz, D., Mannick, J., Takada, K., and Kieff, E. (1992). Phenotypes of Epstein-Barr virus LMP1 deletion mutants indicate transmembrane and amino-terminal cytoplasmic domains necessary for effects in B-lymphoma cells. J. Virol. 66, 4612-4616.
29. Liu, Y., Wang, X., Lo, A. K. F., Wong, Y. C., Cheung, A. L. M., and Tsao, S. W. (2002). Latent membrane protein-1 of Epstein-Barr virus inhibits cell growth and induces sensitivity to cisplatin in nasopharyngeal carcinoma cells. J. Med. Virol. 66, 63-69.
30. Lock, R. B., and Stribinskiene, L. (1996). Dual modes of death by etoposide in human epithelial tumor cells allows Bcl-2 to inhibit apoptosis without affecting clonogenic survival. Cancer Res. 56, 4006-4012.
31. Lu, J. J., Chen, J. Y., Hsu, T. Y., Yu, W. C., Su, I. J., and Yang, C. S. (1996). Induction of apoptosis in epithelial cells by Epstein-Barr virus latent membrane protein 1. J. Gen. Virol. 77, 1883-1892.
32. Mandal, M., Maggirwar, S. B., Sharma, N., Kaufmann, S. H., Sun, S. C., and Kumar, R. (1996). Bcl-2 prevents CD95 (Fas/APO-1)-induced degradation of lamin B and poly(ADP-ribose) polymerase and restores the NF-kappaB signaling pathway. J. Biol. Chem. 271, 30354-30359.
33. Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., Munday, N. A., Raju, S. M., Smulson, M. E., Yamin, T. T., Yu, V. L., and Miller, D. K. (1995). Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376, 37-43.
34. Okan, I., Wang, Y., Chen, F., Hu, L. F., Imreh, S., Klein, G., and Wiman, K. G. (1995). The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest. Oncogene 11, 1027-1031.
35. Opipari, A. W., Hu, H. M., Yabkowitz, R., and Dixit, V. M. (1992). The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J. Biol. Chem. 267, 12424-12427.
36. Pathmanathan, R., Prasad, U., Sadler, R., Flynn, K., and Raab-Traub, N. (1995). Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N. Engl. J. Med. 333, 693-698
37. Robertson, J. D., Gogvadze, V., Zhivotovsky, B., and Orrenius, S. (2000). Distinct pathways for stimulation of cytochrome c release by etoposide. J. Biol. Chem. 275, 32438-32443.
38. Samali, A., Zhivotovsky, B., Jones, D., Nagata, S., and Orrenius, S. (1999). Apoptosis: Cell death defined by caspase activation. Cell Death Differ. 6, 459-496.
39. Sbih-Lammali, F., Clausse, B., Ardila-Osorio, H., Guerry, R., Talbot, M., Havouis, S., Ferradini, L., Bosq, J., Tursz, T., and Busson, P. (1999). Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: Opposite effects of CD95 and CD40 stimulation. Cancer Res. 59, 924-930
40. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K. M., Krammer, P. H., and Peter, M. E. (1998). Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17, 1675-1687.
41. Sheu, L. F., Chen, A., Wei, Y. H., Ho, K. C., Cheng, J. Y., Meng, C. L., and Lee, W. H. (1998). Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis. Am. J. Pathol. 152, 63-74.
42. Sun, X. M., MacFarlane, M., Zhuang, J., Wolf, B. B., Green, D. R., and Cohen, G. M. (1999). Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 274, 5053-5060.
43. Tarodi, B., Subramanian, T., and Chinnadurai, G. (1994). Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection. Virology 201, 404-407.
44. Thomson, B. J. (2001). Viruses and apoptosis. Int. J. Exp. Pathol. 82, 65-76
45. Uchida, J., Yasui, T., Takaoka-Shichijo, Y., Muraoka, M., Kulwichit, W., Raab-Traub, N., and Kikutani, H. (1999). Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science 286, 300-303.
46. Wade, M., and Allday, M. J. (2000). Epstein-Barr virus suppresses a G(2)/M checkpoint activated by genotoxins. Mol. Cell. Biol. 20, 1344-1360.
47. Wang, S., Rowe, M., and Lundgren, E. (1996). Expression of the Epstein-Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homolog Mcl-1 levels in B-cell lines. Cancer Res. 56, 4610-4613.
48. Yin, D. X., and Schimke, R. T. (1995). BCL-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells. Cancer Res. 55, 4922-4928.
49. Yin, X. M., Wang, K., Gross, A., Zhao, Y., Zinkel, S., Klocke, B., Roth, K. A., and Korsmeyer, S. J. (1999). Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400, 886-891.
50. Young, L. S., Eliopoulos, A. G., Gallagher, N. J., and Dawson, C. W. (1998). CD40 and epithelial cells: Across the great divide. Immunol. Today 19, 502-506.
51. Zhivotovsky, B., Joseph, B., and Orrenius, S. (1999). Tumor radiosensitivity and apoptosis. Exp. Cell Res. 248, 10-17.